First Patient Treated in The Phase 2/3 Trial, Assessing Higher Doses of Spinraza

from The Spinal Muscular Atrophy Podcast with Kevin Schaefer · host SMA News Today

Forums Director Kevin Schaefer writes about a new at-home exercise routine he’s developed, using his electric ceiling lift.SMA News Today’s multimedia associate, Price Wooldridge, discusses the first patient treated in the Phase 2/3 trial, assessing higher doses of Spinraza.Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/

Episode metadata supplied by the publisher feed · Published Apr 24, 2020

Embed this episode

Attribution link and audio player

Ready to play

First Patient Treated in The Phase 2/3 Trial, Assessing Higher Doses of Spinraza

0:00 6:18

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Spinal Muscular Atrophy Podcast with Kevin Schaefer?

This episode is 6 minutes long.

When was this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode published?

This episode was published on April 24, 2020.

Can I download this The Spinal Muscular Atrophy Podcast with Kevin Schaefer episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!